Refine
Has Fulltext
- yes (41)
Is part of the Bibliography
- yes (41) (remove)
Year of publication
Document Type
Keywords
- Toxikologie (17)
- DNA damage (9)
- micronuclei (4)
- Micronuclei (3)
- actinomycetes (3)
- oxidative stress (3)
- 5-Azacytidine (2)
- DNA repair (2)
- Diethylstilbestrol (2)
- Electropermeabilization (2)
Institute
- Institut für Pharmakologie und Toxikologie (40)
- Theodor-Boveri-Institut für Biowissenschaften (4)
- Julius-von-Sachs-Institut für Biowissenschaften (3)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (2)
- Augenklinik und Poliklinik (1)
- Institut für Molekulare Infektionsbiologie (1)
- Institut für Organische Chemie (1)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (1)
- Medizinische Klinik und Poliklinik I (1)
- Medizinische Klinik und Poliklinik II (1)
EU-Project number / Contract (GA) number
- 311932 (2)
The rate limiting step in 5-fluorouracil catabolism is catalyzed by the enzyme dihydropyrimidine dehydrogenase. Since degradation of 5-fluorouracil decreases its efficacy in chemotherapy, the inhibition of its catabolism is a promising tool. We investigated the formation of micronuclei in vitro in mouse L5178Y cells. 5-fluorouracil induced an increase in micronucleus frequency, which could significantly be enhanced by the concurrent application of 2,6-dihydroxypyridine, an inhibitor of dihydropyrimidine dehydrogenase. The 5-fluorouracil concentration necessary to reach maximal genotoxic effects could be reduced to half in the presence of inhibitor. 2,6-Dihydroxypyridine alone and the naturally occuring enzyme substrate uracil did not induce micronucleus formation. Combined application of the chemotherapeutic agent 5-fluorouracil and an inhibitor of its could reduce side-effects by lowering the effective dose of the active drug. With this study we provide further support for the usefulness of this concept.